Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amgen (AMGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Merck's (MRK) Keytruda Gets FDA Nod for Solid Tumor Cancers

Merck & Co., Inc. (MRK) announced that Keytruda, has received accelerated approval for the treatment of microsatellite instability-high (MSI-H) or mismatch repair deficient solid tumors .

MRK : 64.93 (+0.59%)
LLY : 77.96 (-0.04%)
AMGN : 154.60 (+0.34%)
GSK : 42.95 (-0.02%)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amgen Inc. (AMGN)

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amgen, Inc. ("Amgen" or the "Company") (NASDAQ: AMGN). Such investors are encouraged...

AMGN : 154.60 (+0.34%)
Today's Research Reports on Stocks to Watch: Radius Health and Biocept Inc.

NEW YORK, NY / ACCESSWIRE / May 23, 2017 / Amgen's bad day has turned into a winning victory for Radius. Radius' shares rallied after it was revealed that rival Amgen's osteoporosis drug candidate could...

BIOC : 1.48 (unch)
RDUS : 37.37 (+0.57%)
AMGN : 154.60 (+0.34%)
Deloitte Debuts ConvergeHEALTH Evidence Lifecycle Management Solutions that Support Shift to Value Based, Personalized Health Care at 2017 Bio-IT World Conference

This year at the 2017 Bio-IT World Conference & Expo, Deloitte will be showcasing the latest updates to its ConvergeHEALTH suite of life sciences end-to-end evidence lifecycle management solutions, as...

AMGN : 154.60 (+0.34%)
Asian shares drift as blast in Manchester rattles investors

TOKYO (AP) — Asian shares were mostly higher in early trading Tuesday after police said they were treating an explosion in Manchester, England, that killed at least 19 people as a terror attack. Oil...

HUN : 24.61 (-2.38%)
LMT : 280.05 (+0.61%)
CSCO : 31.49 (-0.85%)
F : 10.96 (-0.81%)
AMGN : 154.60 (+0.34%)
SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Amgen Inc.

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Amgen Inc. ("Amgen" or the "Company") (Nasdaq: AMGN)....

AMGN : 154.60 (+0.34%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amgen Inc. - AMGN

Pomerantz LLP is investigating claims on behalf of investors of Amgen Inc. ("Amgen" or the "Company") (NASDAQ: AMGN). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com...

AMGN : 154.60 (+0.34%)
Astrazeneca (AZN) Gets Positive CHMP Opinion for Brodalumab

Astrazeneca PLC (AZN) and its partner LEO Pharma received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).

AZN : 34.27 (+0.56%)
VVUS : 1.10 (-1.79%)
AMGN : 154.60 (+0.34%)
VRX : 12.93 (-2.85%)
Amgen Falls 2.15% on Heavy Volume: Watch For Potential Rebound

Amgen (NASDAQ:AMGN) traded in a range yesterday that spanned from a low of $152.66 to a high of $154.60. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $156.29 on...

AMGN : 154.60 (+0.34%)
Amgen Evenity Approval Derailed on Cardiovascular Side Effect

A late-stage study at Amgen, Inc. (AMGN) showed that its pipeline candidate Evenity/romosozumab led to a statistically significant superior fracture risk reduction.

AKTX : 6.51 (-9.21%)
VVUS : 1.10 (-1.79%)
MRK : 64.93 (+0.59%)
AMGN : 154.60 (+0.34%)
George Bennett Rides to Victory in Pasadena at the 2017 Amgen Tour of California

After cycling for seven days and 583 miles across California, Team LottoNL-Jumbo's George Bennett (NZL) claimed the 2017 Amgen Tour of California race championship today in Pasadena with...

AMGN : 154.60 (+0.34%)
Amgen (AMGN) Submits BLA to FDA for Migraine Drug Erenumab

Amgen Inc. (AMGN) recently announced the submission of a biologics license application (BLA) to the FDA for its pipeline candidate erenumab (AMG 334) for the prevention of migraine.

AGN : 224.16 (+1.59%)
NVS : 81.40 (+0.42%)
TEVA : 28.98 (+0.76%)
AMGN : 154.60 (+0.34%)
Merck's (MRK) Keytruda Gets FDA Nod for Two New Indications

Merck & Co., Inc. (MRK) announced that the FDA has approved two new indications for Keytruda (pembrolizumab), the company's anti-PD-1 therapy.

MRK : 64.93 (+0.59%)
AMGN : 154.60 (+0.34%)
PFE : 32.05 (-0.28%)
GSK : 42.95 (-0.02%)
AbbVie Down on Humira Patent Loss: Is More Damage in Store?

AbbVie Inc.'s (ABBV) shares declined more than 2% on Wednesday after it lost a lawsuit related to a patent protecting its key rheumatoid arthritis drug, Humira to small biotech Coherus BioSciences, Inc....

AGN : 224.16 (+1.59%)
CHRS : 20.40 (-6.64%)
ABBV : 65.93 (+0.14%)
AMGN : 154.60 (+0.34%)
Amgen Submits Biologics License Application To The FDA For Erenumab

Amgen (NASDAQ:AMGN) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for erenumab to prevent migraine. Erenumab is specifically designed...

AMGN : 154.60 (+0.34%)
After Yesterday's Decline of 1.20%, Amgen Offers Investors Better Value

Amgen (NASDAQ:AMGN) traded in a range yesterday that spanned from a low of $156.98 to a high of $159.29. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $158.71 on...

AMGN : 154.60 (+0.34%)
Celgene's (CELG) Revlimid Looks Solid on Label Expansion

Celgene's key growth driver, Revlimid, continues to outperform on the back of market share gains and increased duration.

CELG : 117.75 (+0.38%)
VVUS : 1.10 (-1.79%)
ABBV : 65.93 (+0.14%)
AMGN : 154.60 (+0.34%)
Lilly's Migraine Drug Phase III Trials Meet Primary Endpoint

Eli Lilly and Company (LLY) recently announced that its migraine candidate, galcanezumab, met primary endpoint in phase III studies

ALDR : 16.90 (-2.87%)
LLY : 77.96 (-0.04%)
TEVA : 28.98 (+0.76%)
AMGN : 154.60 (+0.34%)
The Zacks Analyst Blog Highlights: J.C. Penney, Amazon, Verizon, Citigroup and Amgen

The Zacks Analyst Blog Highlights: J.C. Penney, Amazon, Verizon, Citigroup and Amgen

C : 62.27 (+0.91%)
VZ : 45.04 (-0.97%)
JCP : 4.65 (+0.65%)
AMGN : 154.60 (+0.34%)
AMZN : 980.35 (+0.91%)
Berkeley Lights, Inc. Announces Expanded Adoption of the Beacon(TM) Opto-Fluidic Platform

Berkeley Lights, Inc., (BLI), a company dedicated to the development of transformational technologies for biopharmaceutical processes, announced today that Amgen has purchased additional Beacon Opto-Fluidic...

AMGN : 154.60 (+0.34%)

Van Meerten Stock Picks

5 All Time High Large Caps for Momentum Investors
This morning I wanted to find 5 Large Caps that hit All Time Highs that might be of interest to Momentum Investors.
AON +0.63 , BAP -1.16 , BF.B +0.96 , VEEV +0.58 , ROL +0.32
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Jun E-mini S&Ps ( ESM17 -0.02% ) this morning are down -0.03% and European stocks are down -0.26% after the ECB warned in its Financial Stability Review that "risks to financial stability stemming from... Read More

Chart of the Day

Equinix (EQIX) is the Barchart Chart of the Day.  The computer building REIT has  Trend Spotter buy signal, a Weighted Alpha of 26.71 and gained 24.09% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures closed 1 3/4 to 2 cents higher. The weekly EIA report this morning had daily ethanol production at 1.01 million barrels per day last week. It showed ethanol production dropping 17,000 bpd over the week of May 19. Ethanol stocks dropped b...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.